page0904 |
Previous | 1 of 7 | Next |
|
|
Loading content ...
Continuous Feed Centrifuge Replaces Flotation for Removal of Excess Activated Sludge from a Pharmaceutical Wastewater Treatment Plant MARK R. STUMPF, Manager Waste Control Department WILLIAM H. HARPER, Process Development Engineer Abbott Laboratories North Chicago, Illinois ABBOTT'S APPROACH TO POLLUTION CONTROL Abbott Laboratories is a major pharmaceutical manufacturer with a number of manufacturing plants in the United States; the plant at North Chicago being by far the largest. This plant occupies some 56 acres and is located about one-half mile west of Lake Michigan. At this plant we employ approximately 6,000 people and conduct extensive manufacturing and research operations. Two of the antibiotics produced here by fermentation are erythromycin and penicillin. Fine chemicals produced by reaction and synthesis include sedatives, diuretics, antihypertensives, anti-coagulants, anti-convulsants, laxatives and anti-dandruff preparations. We also manufacture intravenous and irrigation solutions and equipment, vitamin and cough preparations, as well as animal feed and health products. At our North Chicago plant we use a systems approach to prevent water pollution. Our objective is to minimize the total pollution which results from production operations, natural occurrences, and accidental spillage. To do this we conduct many different types of treatment operations. Included among these are the recovery and recycle type of treatment operations, cleanup of spent water, control of accidental spillage, and the operation of a wastewater treatment plant. Among our treatment systems, we consider the recovery group to be the most important; more than three-fourths of our potential waste streams, expressed on a BOD basis, are processed through recovery systems. Unfortunately, not everything can be recovered and some wastes must be sewered. Sanitary wastes are sent to the North Shore Sanitary District plant at North Chicago. Sewered processed wastes are sent to the unique Abbott activated sludge wastewater treatment plant which was developed and designed specifically for this concentrated industrial waste stream. This plant has a hydraulic and biochemical oxygen demand (BOD) loading capacity of 1,000,000 gallons per day and 30.000 pounds of BOD applied per day at an average performance level of 94 percent BOD removal, with a range of 85 to 98 percent. The BOD concentration of the sewered process waste stream averages 3000 mg/1 and consists of residual sugars, starches, vegetable oils, and trace minerals not consumed in the fermentation facilities as well as organic chemicals and hydrocarbons from the manufacture of fine chemicals. This particular waste combination causes a highly filamentous activated sludge which is difficult to remove and thicken by conventional methods. WASTE SLUDGE, THE END PRODUCT One of the end products of the biochemical reactions when stabilizing biochemical oxygen demand (BOD) in an activated sludge plant is cellular matter which, under equilibrium operation, is usually thought of as excess or waste sludge. In the presence of excess food, the microorganisms in a normal wastewater treatment plant will multiply rapidly. This increase in microbial population, or creation of more sludge, is the synthesis 904
Object Description
Purdue Identification Number | ETRIWC197280 |
Title | Continuous feed centrifuge replaces flotation for removal of excess activated sludge from a pharmaceutical wastewater treatment plant |
Author |
Stumpf, Mark R. Harper, William H. |
Date of Original | 1972 |
Conference Title | Proceedings of the 27th Industrial Waste Conference |
Conference Front Matter (copy and paste) | http://earchives.lib.purdue.edu/u?/engext,20246 |
Extent of Original | p. 904-910 |
Series | Engineering extension series no. 141 |
Collection Title | Engineering Technical Reports Collection, Purdue University |
Repository | Purdue University Libraries |
Rights Statement | Digital object copyright Purdue University. All rights reserved. |
Language | eng |
Type (DCMI) | text |
Format | JP2 |
Date Digitized | 2009-06-08 |
Capture Device | Fujitsu fi-5650C |
Capture Details | ScandAll 21 |
Resolution | 300 ppi |
Color Depth | 8 bit |
Description
Title | page0904 |
Collection Title | Engineering Technical Reports Collection, Purdue University |
Repository | Purdue University Libraries |
Rights Statement | Digital object copyright Purdue University. All rights reserved. |
Language | eng |
Type (DCMI) | text |
Format | JP2 |
Capture Device | Fujitsu fi-5650C |
Capture Details | ScandAll 21 |
Transcript | Continuous Feed Centrifuge Replaces Flotation for Removal of Excess Activated Sludge from a Pharmaceutical Wastewater Treatment Plant MARK R. STUMPF, Manager Waste Control Department WILLIAM H. HARPER, Process Development Engineer Abbott Laboratories North Chicago, Illinois ABBOTT'S APPROACH TO POLLUTION CONTROL Abbott Laboratories is a major pharmaceutical manufacturer with a number of manufacturing plants in the United States; the plant at North Chicago being by far the largest. This plant occupies some 56 acres and is located about one-half mile west of Lake Michigan. At this plant we employ approximately 6,000 people and conduct extensive manufacturing and research operations. Two of the antibiotics produced here by fermentation are erythromycin and penicillin. Fine chemicals produced by reaction and synthesis include sedatives, diuretics, antihypertensives, anti-coagulants, anti-convulsants, laxatives and anti-dandruff preparations. We also manufacture intravenous and irrigation solutions and equipment, vitamin and cough preparations, as well as animal feed and health products. At our North Chicago plant we use a systems approach to prevent water pollution. Our objective is to minimize the total pollution which results from production operations, natural occurrences, and accidental spillage. To do this we conduct many different types of treatment operations. Included among these are the recovery and recycle type of treatment operations, cleanup of spent water, control of accidental spillage, and the operation of a wastewater treatment plant. Among our treatment systems, we consider the recovery group to be the most important; more than three-fourths of our potential waste streams, expressed on a BOD basis, are processed through recovery systems. Unfortunately, not everything can be recovered and some wastes must be sewered. Sanitary wastes are sent to the North Shore Sanitary District plant at North Chicago. Sewered processed wastes are sent to the unique Abbott activated sludge wastewater treatment plant which was developed and designed specifically for this concentrated industrial waste stream. This plant has a hydraulic and biochemical oxygen demand (BOD) loading capacity of 1,000,000 gallons per day and 30.000 pounds of BOD applied per day at an average performance level of 94 percent BOD removal, with a range of 85 to 98 percent. The BOD concentration of the sewered process waste stream averages 3000 mg/1 and consists of residual sugars, starches, vegetable oils, and trace minerals not consumed in the fermentation facilities as well as organic chemicals and hydrocarbons from the manufacture of fine chemicals. This particular waste combination causes a highly filamentous activated sludge which is difficult to remove and thicken by conventional methods. WASTE SLUDGE, THE END PRODUCT One of the end products of the biochemical reactions when stabilizing biochemical oxygen demand (BOD) in an activated sludge plant is cellular matter which, under equilibrium operation, is usually thought of as excess or waste sludge. In the presence of excess food, the microorganisms in a normal wastewater treatment plant will multiply rapidly. This increase in microbial population, or creation of more sludge, is the synthesis 904 |
Resolution | 300 ppi |
Color Depth | 8 bit |
Tags
Comments
Post a Comment for page0904